Side-by-side comparison of AI visibility scores, market position, and capabilities
BenchSci is an AI-powered biomedical research intelligence platform used by 16 of the top 20 pharma companies; accelerates experiment design by analyzing millions of scientific papers and proprietary data to recommend validated reagents and.
BenchSci is a Toronto-based life sciences AI company founded in 2015 by Tom Leung, Elvis Wianda, Liran Belenzon, and David Chen. The company builds AI-powered research intelligence software that helps biomedical scientists — particularly at pharmaceutical and biotechnology companies — design better experiments faster, reduce failure rates, and avoid duplicating work that has already been done. BenchSci''s platform applies machine learning to analyze both published scientific literature (including open-access and licensed journal databases) and proprietary experimental data from its pharma clients, extracting structured information about reagent performance, experimental protocols, and biological targets to generate recommendations for researchers planning new experiments.
Pioneering organ-on-chip platform installed in 150+ labs including 17 of the top 25 biopharma companies; launched AVA™ high-throughput 96-chip system in 2025 and holds the only FDA ISTAND-accepted DILI Organ-Chip.
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the microstructure and function of human organs. Founded in 2013 as a spin-out from the Wyss Institute at Harvard University, Emulate's chips model the liver, intestine, lung, kidney, brain, and other organ systems with a fidelity that animal models and traditional cell culture cannot match. The technology was originally developed to reduce drug development attrition rates caused by poor translation from animal studies to human clinical outcomes.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.